Kirovest Pharmaceuticals Company S.A.E. (“Kirovest”) is an Egyptian Company established in 1999 under the laws of the Arab Republic of Egypt. Kirovest’s main business includes development, manufacturing, marketing and distribution, of a wide range of human pharmaceutical, cosmetics and animal health products. Kirovest maintains a robust product portfolio that offers a wide range of much needed pharmaceutical therapies and treatments. With a strong product pipeline strategy, Kirovest currently has more than 60 new products at various stages of registration that were carefully selected in order to address many un-met therapeutic needs. Kirovest’s product portfolio and product pipeline will endure further expansions for many years to come and will continue to play a major role in driving the growth of Kirovest.